Update Venetoclax in CLL
Zanubrutinib
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
NCCN Guidelines for Patients for CLL
UpToDate
Patient Power